Tag: Anti-obesity medication

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Anti-obesity medication

Roche's CT-388: A Game-Changer in the Obesity Drug Space? - AInvest

Added to Collection on: 2025-09-22 22:18:55

Tags for this article:

GLP-1 receptor agonists
Anti-diabetic drugs
PEPTIDE THERAPEUTICS
Intestinal hormones
Peptide hormones
CT-388
Glucagon-like peptide-1
Anti-obesity medication
GLP
GLP1 poly-agonist peptides
Dapiglutide
GLP-1

Click the tags to see associated articles and topics

View Article Details
Pharma giants Pfizer and Roche wade into the fat jab fight as they look to develop their own ...

Added to Collection on: 2025-09-22 21:07:45

Tags for this article:

Daily Mail
MailOnline
Symbian software
Pfizer
Facebook
Anti-obesity medication
Semaglutide
Obesity
Like button

Click the tags to see associated articles and topics

View Article Details
Roche moves obesity asset CT-388 into Phase III - European Biotechnology Magazine

Added to Collection on: 2025-09-22 19:54:11

Tags for this article:

Peptide hormones
GLP-1 receptor agonists
PEPTIDE THERAPEUTICS
Intestinal hormones
Lipopeptides
Petrelintide
Anti-obesity medication
Incretin
Glucagon-like peptide-1
CT-388
Tirzepatide
Semaglutide
Graham

Click the tags to see associated articles and topics

View Article Details
Can oral GLP-1RAs deliver on the promise of accessible obesity care?

Added to Collection on: 2025-09-23 22:07:18

Tags for this article:

GLP-1 receptor agonists
Peptide hormones
Anti-diabetic drugs
PEPTIDE THERAPEUTICS
Anorectics
Semaglutide
Anti-obesity medication
Orforglipron
Glucagon-like peptide-1
Novo Nordisk
Diabetes
Insulin

Click the tags to see associated articles and topics

View Article Details
Ascletis' Muscle-Preserving Weight Loss Drug Candidate Displayed Significant ...

Added to Collection on: 2025-09-26 00:55:11

Tags for this article:

GLP-1 receptor agonists
PEPTIDE THERAPEUTICS
Lipopeptides
Peptide hormones
Semaglutide
Anti-obesity medication
Metabolic dysfunction–associated steatotic liver disease
Medroxyprogesterone acetate
Metabolic syndrome
Weight loss
Magnesium in biology
Cagrilintide/semaglutide
Ascletis Pharma Inc.
Adobe
Ascletis Pharma

Click the tags to see associated articles and topics

View Article Details
The dangerous second life of medical waste - Pharmaceutical Technology

Added to Collection on: 2025-09-29 10:11:05

Tags for this article:

Pharmaceuticals policy
Counterfeit medications
Semaglutide
GLP-1 receptor agonist
Counterfeit
Pharmacy
Anti-obesity medication
Authentication
Medication
Shutterstock

Click the tags to see associated articles and topics

View Article Details
Here's Why Morgan Stanley Analysts Downgraded Novo Nordisk's Stock - Investopedia

Added to Collection on: 2025-09-29 17:56:25

Tags for this article:

Peptide hormones
Anti-diabetic drugs
GLP-1 receptor agonists
PEPTIDE THERAPEUTICS
Novo Nordisk
Semaglutide
Anti-obesity medication
Glucagon-like peptide-1
Eli Lilly and Company
Cagrilintide/semaglutide

Click the tags to see associated articles and topics

View Article Details
Amy Schumer displays 'legs for days' as comedian continues her weight-loss journey

Added to Collection on: 2025-10-05 23:05:49

Tags for this article:

GLP-1 receptor agonists
PEPTIDE THERAPEUTICS
In Denmark
Lipopeptides
Semaglutide
Schumer
Anti-obesity medication
Chris Fischer
GDF15
Amy Schumer

Click the tags to see associated articles and topics

View Article Details
Watch Out Eli Lilly, This Pharma Giant Is Gunning to Be a Top Player in the Obesity Market

Added to Collection on: 2025-10-09 18:19:49

Tags for this article:

Research and development in the United States
GLP-1 receptor agonists
Eli Lilly and Company
PEPTIDE THERAPEUTICS
The Motley Fool
Eli Lilly
Pfizer
Tirzepatide
Anti-obesity medication

Click the tags to see associated articles and topics

View Article Details
IP Group eyes potential royalties from obesity drug - The Armchair Trader

Added to Collection on: 2025-10-13 07:13:15

Tags for this article:

Anti-diabetic drugs
Research and development in the United States
Peptide hormones
GLP-1 receptor agonists
Lipopeptides
Pfizer
Glucagon-like peptide-1
Royalty payment
Eli Lilly and Company
Semaglutide
IP Group
Anti-obesity medication
Metsera Inc.
IP Group plc

Click the tags to see associated articles and topics

View Article Details
Book a Demo